ImmunityBio, Inc. (IBRX) vs Vaxcyte, Inc. (PCVX)
ImmunityBio, Inc. and Vaxcyte, Inc. are both Biotechnology companies. ImmunityBio, Inc. and Vaxcyte, Inc. are of similar size ($9.2B and $8.5B). Vaxcyte, Inc. has the higher net margin (0.00% vs −598.6%) and the lower return on invested capital (−57.3% vs 0.00%). Across the 13 metrics below, ImmunityBio, Inc. leads on 8 and Vaxcyte, Inc. on 5.
Valuation
Profitability
| Metric | IBRX | PCVX | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.34% | 0.00% | 65.16% |
| Operating margin | (151.88%) | 0.00% | 0.00% |
| Net margin | (598.56%) | 0.00% | 0.00% |
| Free cash flow margin | (173.76%) | 0.00% | 0.00% |
| Return on equity | 122.85% | (36.51%) | (57.72%) |
| Return on assets | (192.58%) | (33.03%) | (49.22%) |
| Return on invested capital | 0.00% | (57.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack